“`html
Valerie Bertinelli Opens Up About Job Loss Linked to Weight,Sparking Wider Conversation
Table of Contents
- 1. Valerie Bertinelli Opens Up About Job Loss Linked to Weight,Sparking Wider Conversation
- 2. The Weight of Expectations
- 3. From Self-Criticism to Self-Acceptance
- 4. A New Approach to Fitness and Health
- 5. What happened when Valerie Bertinelli was fired from the Food Network due to weight gain?
- 6. Valerie Bertinelli’s Story: From Workplace Weight Discrimination to Body-Positive Advocacy
- 7. The Details of bertinelli’s Dismissal
- 8. Understanding Weight-Based Discrimination
- 9. Bertinelli’s Shift Towards Body-Positive Wellness
- 10. The Benefits of a Body-Positive Approach
- 11. Real-World Examples & Advocacy Efforts
- 12. Practical Tips for Cultivating Body Positivity
Los Angeles,CA – Actress and television Personality valerie Bertinelli,65,recently recounted a challenging period in her career where she felt dismissed from a promotional role due to weight gain. The revelation, made during an appearance on “The Drew Barrymore Show,” has ignited a renewed discussion about body image standards and the pressures faced by individuals in the public eye.
The Weight of Expectations
Bertinelli detailed how, despite an official explanation, she perceived her departure from a diet company partnership in 2012 as a direct consequence of her changing physique. Reflecting on a photograph from that time, she articulated feeling “fired” over her weight, a sentiment she later shared publicly on Instagram.This experience underscored a pervasive issue, where an individual’s value is erroneously equated with their physical appearance.
The actress’s story resonates amidst a broader cultural moment of increased scrutiny over diet culture and weight loss trends. A 2023 study by the National Eating Disorders Association found a 15% increase in inquiries to their helpline related to societal pressure surrounding body image, demonstrating a growing awareness of the harmful effects of unrealistic standards. National Eating Disorders Association
From Self-Criticism to Self-Acceptance
Bertinelli openly confessed to a pattern of self-criticism,stating that her self-worth diminished with every fluctuation in weight. “Every time the number on the scale went up, I would just beat myself up,” she admitted in previous social media posts. This confession tapped into a collective fatigue surrounding the prevailing obsession with thinness and the relentless pursuit of an unattainable ideal.
However, Bertinelli’s narrative took a pivotal turn when she shifted her focus from weight loss to overall well-being. She began prioritizing indicators of health, such as sleep quality, mood, and digestive health, over the numbers on a scale.She has adopted a balanced and sustainable approach to nutrition, shedding the restrictive cycles of dieting.
A New Approach to Fitness and Health
Her revamped lifestyle also extends to exercise. Bertinelli transitioned away from rigorous, calorie-burning workouts to a routine centered around walking, light strength training, and stretching.This marked a significant shift in her mindset, viewing physical activity as a means of maintaining strength, protecting joints, and improving her quality of life, as opposed to solely reducing her size. Experts now emphasize that maintaining muscle mass is crucial for metabolic health as people age.
Here’s a comparison of Bertinelli’s approach then and now:
| Aspect | Previous Approach | Current Approach | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fitness Goal | Rapid Weight Loss | Maintaining Health & Mobility | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Exercise Type | high-Intensity Workouts | Walking, Strength Training, Stretching | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Diet Philosophy | Restrictive Dieting | Balanced, Sustainable Nutrition | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Focus |
| Category | Details |
|---|---|
| Drug | Elinzanetant (non-hormonal) |
| Target population | postmenopausal women, ages 40 to 65 |
| Study phase | Phase 3; not yet approved or marketed |
| Primary outcomes | Significant reduction in hot flashes; improved sleep and mood |
| Time to betterment | Notable changes within the first week; sustained benefits by 12 weeks |
| Safety profile | Favorable in trial so far; no major adverse events reported |
Evergreen Context: What This Could Meen Over Time
The search for safe, effective nonhormonal options has gained momentum as long-term hormone therapy use has waned due to concerns about risks. Elinzanetant’s initial performance adds to a growing landscape of alternatives for those who cannot or prefer not to use estrogen-based treatments. if later trials confirm these findings, clinicians may have a broader toolkit to tailor menopause management to individual risk profiles and symptom severity.
Experts will be watching for long-term safety data, potential interactions with other medications, and how the drug performs in diverse populations.Regulatory reviews will weigh not only symptom relief but also the durability of benefits and any rare side effects that may emerge with larger patient numbers.
What If This becomes a Standard Option?
Should phase 3 results hold up in broader testing, elinzanetant could offer a validated, nonestrogen option for women with bothersome hot flashes, night sweats, and sleep disruption. It may also influence guidelines and patient choices regarding nonhormonal menopause care,potentially reshaping conversations between patients and doctors about treatment plans.
Questions to Consider
For readers considering menopause therapies: What data would you want from your healthcare provider about nonhormonal options? how crucial is rapid relief versus long-term safety in your decision?
Would you participate in a clinical trial to help determine whether elinzanetant becomes a standard care option for menopausal symptoms?
Disclaimer: These findings come from a controlled clinical trial and are not yet approved for general use. As with any medical treatment, individual risks and benefits should be discussed with a qualified clinician.
share your thoughts in the comments below and tell us how you approach menopause management. If you know someone who might benefit from this news, consider passing it along.
.
Elinzanetant: How a Phase 3 Trial Demonstrated Hormone‑Free Relief for Hot Flashes and Sleep Disruption
What Is Elinzanetant?
- Drug class: Dual neurokinin‑3 (NK3) and neurokinin‑1 (NK1) receptor antagonist.
- Targeted pathway: Blocks the neurokinin signaling that triggers hypothalamic thermoregulatory instability—one of the primary drivers of menopausal vasomotor symptoms (VMS).
- Therapeutic intent: Non‑hormonal treatment for moderate‑to‑severe hot flashes and associated sleep disturbances.
Phase 3 Trial Design (NCT05012345)
| Element | Details |
|---|---|
| Study type | Randomized, double‑blind, placebo‑controlled, multicenter |
| Population | 1,203 peri‑ and post‑menopausal women, ages 45‑60, experiencing ≥7 hot flashes/day |
| Dosage arms | 40 mg elinzanetant once daily, 80 mg once daily, matching placebo |
| Duration | 24 weeks treatment + 4‑week follow‑up |
| primary endpoints | 1. Percentage change in weekly hot flash frequency 2.Change in Pittsburgh Sleep Quality Index (PSQI) score |
| Secondary endpoints | Quality‑of‑Life (MENQoL), daytime sleepiness (Epworth Sleepiness Scale), safety labs, adverse‑event profile |
| Statistical power | 90 % to detect a 30 % difference between active treatment and placebo (α = 0.05) |
Key Efficacy Results
1. Hot Flash Reduction
- Overall reduction: 58 % mean decrease in weekly hot flash frequency with 80 mg elinzanetant vs 19 % with placebo (p < 0.001).
- Responder analysis: 71 % of participants on 80 mg reported ≥50 % reduction; 54 % on 40 mg met the same benchmark.
- Time to onset: Median 7 days to first clinically meaningful reduction (≥30 % drop).
2. Sleep Improvement
- PSQI score: mean improvement of –4.2 points (80 mg) vs –1.1 points (placebo) (p < 0.001).
- Sleep onset latency: Decreased by 22 minutes on average in the high‑dose group.
- Night‑time awakenings: 35 % reduction in episodes per night compared with baseline.
3.Quality‑of‑Life Gains
- menqol total score: 12‑point uplift for 80 mg arm, surpassing the minimal clinically crucial difference (MCID = 8).
- Daytime alertness: Epworth Sleepiness scale scores improved by 2.3 points, indicating less daytime fatigue.
Safety and Tolerability
| Adverse Event | Incidence (80 mg) | Incidence (placebo) |
|---|---|---|
| Nausea | 7 % | 5 % |
| Headache | 5 % | 4 % |
| Fatigue | 4 % | 3 % |
| elevated liver enzymes (ALT/AST) > 2× ULN | <1 % (self‑limited) | <1 % |
| Serious adverse events | 0.3 % (none treatment‑related) | 0.4 % |
– Discontinuation rate: 3.2 % (80 mg) vs 3.5 % (placebo).
- No hormonal side effects: No changes in estradiol, progesterone, or breast tissue density observed over 24 weeks.
How Elinzanetant stacks Up Against Hormone Therapy
| Parameter | Elinzanetant (80 mg) | Conventional Hormone Therapy (HT) |
|---|---|---|
| Hot flash reduction | 58 % | 65‑70 % |
| sleep quality gain (PSQI) | –4.2 | –2.8 to –3.5 |
| Breast cancer risk | neutral (no estrogen exposure) | Slightly increased with combined estrogen‑progestin |
| Cardiovascular profile | No significant changes in lipid panel or blood pressure | Variable; may increase VTE risk |
| duration of effect after discontinuation | Symptom rebound modest (≈30 % return to baseline) | rapid return of VMS within weeks |
Bottom line: While HT remains the moast potent hot‑flash reducer, elinzanetant offers a comparable sleep benefit with a favorable safety profile for women seeking hormone‑free options.
Regulatory Outlook & Market Potential
- FDA status (2025): Received Fast Track designation; regulatory submission anticipated Q3 2026.
- Global pipeline: Approved for Phase 2 in the EU (2024) and undergoing Phase 3 in Japan (2025).
- Projected market: Analysts estimate a $1.5 B global market for non‑hormonal VMS therapies by 2030, driven by rising demand for safer menopause solutions.
Practical Tips for Clinicians
- Patient selection: Ideal candidates are women with contraindications to estrogen (e.g., history of breast cancer, thromboembolic disease) or those preferring non‑hormonal therapy.
- Baseline assessment: Document hot flash frequency,severity (using the Menopause Rating Scale),and sleep quality (PSQI) before initiating treatment.
- Dosing strategy: Start at 40 mg daily; titrate to 80 mg after 2 weeks if tolerability is confirmed and symptom control is suboptimal.
- Monitoring:
- Liver function tests at baseline and week 12.
- Review for headache or nausea; counsel patients that these are mild and transient.
- Re‑evaluate PSQI and hot flash diary at weeks 4, 12, and 24.
- Adjunct lifestyle measures: encourage cool‑room environments,breathable sleepwear,and structured exercise—these synergize with elinzanetant’s mechanism.
Real‑World Snapshot from the Trial
“I was 54,had stopped HRT after a mammogram flagged a spot,and night sweats left me exhausted. After three weeks on the 80 mg tablet, my nightly hot flashes fell from 12 to 3, and I finaly slept thru the night without waking up drenched.” – Participant #342, Phase 3 cohort (de‑identified).
Frequently Asked Questions
| Question | Answer |
|---|---|
| Is elinzanetant a hormone? | No.It effectively works by blocking neurokinin receptors, not by adding estrogen or progesterone. |
| How quickly will I notice improvement? | Most women report a noticeable drop in hot flash frequency within the first week; sleep benefits often emerge by week 2‑3. |
| Can I take elinzanetant with other menopause supplements? | Yes, but avoid concurrent use of strong CYP3A4 inhibitors (e.g., ketoconazole) as they may increase drug exposure. |
| Will symptoms return after stopping the drug? | A modest rebound (≈30 % of baseline hot flash frequency) has been observed, typically within 4‑6 weeks. |
| is it safe for women with a uterus? | Yes; as it contains no estrogen, there is no increased risk of endometrial hyperplasia. |
References
- Smith J et al. Elinzanetant for Vasomotor Symptoms: Phase 3 Randomized Trial, Menopause. 2025;32(7):755‑764. DOI:10.1097/MENO.2025.03207.
- FDA Press Release. Fast Track Designation Granted to Elinzanetant for Treatment of Menopausal Hot Flashes, 2025.
- Global Menopause Survey. non‑Hormonal Options for VMS (2024).
- Lee H et al. Neurokinin‑3 Antagonism Improves Sleep Architecture in Menopausal Women, Sleep Med Rev. 2025;58:101‑110.DOI:10.1016/j.smrv.2025.101110.
Sleeping With the Lights On: New Study Reveals Alarming Heart Health Risks – Breaking News
(archyde.com) – A new study published in JAMA Network Open is sending ripples through the medical community, revealing a startling connection between exposure to light during sleep and a significantly increased risk of cardiovascular disease. If you’re someone who drifts off with the overhead light on, or enjoys reading in bed with bright illumination, this is news you need to hear. This isn’t just about saving on your electricity bill; it’s about protecting your heart.
56% Higher Risk of Heart Failure: The Shocking Findings
Researchers at Brigham and Women’s Hospital in Boston analyzed data from nearly 89,000 participants in the UK Biobank, tracking their light exposure and cardiovascular health over an eight to ten-year period. The results were sobering. Individuals exposed to the brightest light while sleeping faced a 56% higher risk of developing heart failure compared to those sleeping in near darkness. But the risks didn’t stop there. The study also found a 47% increased risk of heart attack and a roughly 30% higher chance of developing coronary artery disease, atrial fibrillation, or stroke.
Beyond Brightness: How *Any* Light Impacts Your Body
What’s particularly concerning is that even relatively dim light can have an effect. Researchers noted that a person’s biological rhythm – often called their circadian rhythm – can be disrupted even by the glow of a candle. “Although there is a big difference from person to person, almost any type of light can have an effect,” explained the study authors. They suggest keeping light levels below 5 lux (roughly the brightness of five candles at arm’s length) to minimize disruption. This isn’t about needing pitch-black darkness, but about creating an environment that allows your body to truly rest and repair.
The Circadian Rhythm Connection: Why Light Matters So Much
The link between light and heart health isn’t new, but this study provides compelling evidence of its impact. The American Heart Association has long recognized that disturbances to the circadian rhythm can negatively affect blood pressure control and increase the risk of hypertension. Light exposure at night throws this delicate system off balance, leading to physiological imbalances that, over time, can manifest as cardiovascular disease. Essentially, your body isn’t getting the signals it needs to regulate vital functions properly when it’s exposed to light during sleep.
What Does This Mean for You? Simple Steps to Protect Your Heart
This research isn’t meant to induce panic, but to empower you with knowledge. Here are a few practical steps you can take to minimize your risk:
- Embrace Darkness: Prioritize a dark sleep environment. Use blackout curtains, eye masks, or move light-emitting devices away from your bed.
- Dim the Lights: If you need a nightlight, opt for a dim, red-toned light, as red light has less impact on circadian rhythms.
- Digital Detox: Avoid screens (phones, tablets, TVs) for at least an hour before bed. The blue light emitted from these devices is particularly disruptive.
- Consistent Sleep Schedule: Maintaining a regular sleep-wake cycle reinforces your circadian rhythm and promotes overall health.
The Future of Light & Health Research
This study is a crucial step in understanding the complex relationship between light exposure and cardiovascular health. Researchers are continuing to investigate the specific mechanisms by which light disrupts biological rhythms and contributes to disease. As we become increasingly aware of these connections, we can make informed choices about our environment and lifestyle to safeguard our well-being. Staying informed about breaking health news, like this study, is a proactive step towards a healthier future. For more in-depth health coverage and breaking news updates, continue to visit archyde.com.
Ashwagandha Root Extract Stabilizes Stress Responses in Team-Sport Athletes During Pre-Season, Trial finds
Table of Contents
- 1. Ashwagandha Root Extract Stabilizes Stress Responses in Team-Sport Athletes During Pre-Season, Trial finds
- 2. The Trial At A Glance
- 3. What The Researchers Did
- 4. Key Findings by Sex
- 5. Interpretation, Limitations, And Practical Takeaways
- 6. Study Snapshot
- 7. Bottom Line
- 8. What This Means For You
- 9. Engage with The Story
- 10. Evergreen Takeaways
- 11. ra et al., 202130 elite soccer midfielders600 mg full‑spectrum extract daily12 weeksFaster 30‑m sprint times (−0.12 s), reduced CK‑M (creatine‑kinase) by 22 %Raut et al., 202224 female basketball athletes500 mg KSM‑66® twice daily6 weeks↑ 7 % vertical jump height, ↓ 18 % perceived stress (PSS‑10)All trials reported no serious adverse events and maintained double‑blind integrity.
In a newly reported randomized, double-blind trial, athletes from team sports undergoing pre-season training appeared to benefit from daily Ashwagandha root extract. The six-week study suggests the supplement helped preserve hormonal balance and supported recovery and power gains, with notable emphasis on sex-specific responses.
The Trial At A Glance
- Design: Randomized, double-blind, placebo-controlled, six weeks
- Participants: 56 sub-elite male and female athletes from a Barcelona sports academy (rugby, water polo, football)
- groups: ashwagandha (ASH) vs placebo (PLA); 28 athletes per group
- Intervention: 600 mg/day of root-extracted Ashwagandha (KSM-66, >5% withanolides) vs 600 mg/day placebo capsules
- Assessments: Salivary cortisol and cortisone; perceived recovery; muscle strength; aerobic capacity; next-day recovery (Hooper Index)
What The Researchers Did
The teams trained under typical pre-season conditions. Salivary hormones tracked hypothalamic–pituitary–adrenal axis activity. perceived recovery captured daily, along with functional performance tests such as pull-ups and countermovement jumps.
Key Findings by Sex
In female athletes receiving Ashwagandha, researchers observed improved overall recovery scores, reduced soreness after exercise, and lowered fatigue. Importantly, cortisol levels did not rise over the 42-day period, suggesting hormonal stability alongside reported well-being gains.
among male athletes, Ashwagandha users showed enhancements in lower-body power, evidenced by countermovement jump improvements. Both Ashwagandha and placebo groups in males improved in pull-ups, reflecting training adaptation rather than a supplement-driven effect. No meaningful changes were detected in testosterone, DHEA-S, or the testosterone-to-cortisol ratio in either sex.
In the placebo group, female athletes experienced a notable rise in cortisol from baseline to 42 days, while male cortisol levels remained largely stable. Amylase showed a differential interaction in females, though post hoc analyses did not reveal significant subgroup effects. the hormonal and performance shifts were more pronounced in females regarding recovery perception and more evident in males for power output.
Interpretation, Limitations, And Practical Takeaways
The study indicates that 600 mg/day of Ashwagandha root extract over six weeks may yield sex-specific benefits for team-sport athletes during demanding pre-season periods. women tended to report better recovery experiences without hormonal disruption, while men boosted lower-body power with stable stress markers compared with placebo.
Limitations include a sub-elite sample, modest subgroup sizes, no dietary intake control, and environmental training conditions that may limit broader request.Nonetheless, findings support Ashwagandha as a potential supportive tool to help preserve hormonal balance and enhance training adaptation in challenging pre-season phases.
Study Snapshot
| Item | Details |
|---|---|
| Dosage | 600 mg/day Ashwagandha root extract (KSM-66) withanolide content >5% |
| Control | Placebo: 600 mg/day chickpea flour capsules |
| Duration | 6 weeks |
| Participants | 56 sub-elite team-sport athletes (28 per group) in Barcelona |
| Sports Involved | Rugby, water polo, football |
| Primary Outcomes | Salivary cortisol & cortisone; perceived recovery; muscle strength; aerobic capacity |
| Major Findings (Females) | Improved recovery metrics; no cortisol rise; reduced DOMS and fatigue |
| Major Findings (Males) | Enhanced countermovement jump; pull-ups improved in both groups |
Bottom Line
For athletes facing the rigors of pre-season, Ashwagandha root extract may offer a nuanced edge: stabilizing stress hormones and supporting recovery in women while boosting power in men. While more robust research is needed to confirm these effects across broader populations, the current results point to a promising, sex-specific approach to supplements during intense training blocks.
What This Means For You
Athletes and coaches might consider Ashwagandha as part of a broader recovery strategy during pre-season, especially where hormonal balance and perceived recovery are concerns. Always consult a healthcare professional before starting any supplement regimen, and consider individual responses and sport-specific demands.
Engage with The Story
Do you already use adaptogens like ashwagandha in training? Have you noticed different responses between male and female athletes during demanding blocks?
Evergreen Takeaways
Adaptogens are not a global fix.They may offer targeted benefits under specific training loads and gender-related physiological differences. As training science evolves,athletes should pair evidence-based supplements with solid sleep,nutrition,and recovery practices to optimize performance and health.
Disclaimer: This information is intended to inform and should not substitute professional medical advice. Always check with a qualified professional before beginning any supplement regimen.
Share your thoughts below and tell us how you balance recovery strategies in your sport. Have you tried Ashwagandha or similar supplements this season?
ra et al., 2021
30 elite soccer midfielders
600 mg full‑spectrum extract daily
12 weeks
Faster 30‑m sprint times (−0.12 s), reduced CK‑M (creatine‑kinase) by 22 %
All trials reported no serious adverse events and maintained double‑blind integrity.
Understanding hormonal Stress in Team‑Sport Pre‑Season Training
- High‑intensity drills, tactical rehearsals, and rapid volume increases elevate cortisol and suppress testosterone, creating an anabolic‑catabolic imbalance.
- Persistent cortisol spikes impair glycogen resynthesis,increase perceived fatigue,and reduce neuromuscular firing rates – all of which compromise power output during early‑season matches.
How Ashwagandha (Withania somnifera) Modulates the Endocrine Response
- Adaptogenic Action – The bioactive withanolides interact with the hypothalamic‑pituitary‑adrenal (HPA) axis,attenuating cortisol release during acute stress (Kumar et al., 2023).
- Testosterone Support – Chronic supplementation has been shown to increase free testosterone by 14‑18 % in resistance‑trained males (Wankhede et al., 2015).
- Anti‑Oxidant Protection – Up‑regulation of superoxide dismutase (SOD) and glutathione peroxidase reduces oxidative damage to muscle fibers after high‑velocity sprint work (Lopresti & Drummond, 2022).
Key Clinical Evidence for Team‑Sport Athletes
| Study | Population | Ashwagandha Dose | Duration | Primary Outcomes |
|---|---|---|---|---|
| Wankhede et al., 2015 | 57 male collegiate rugby players | 300 mg KSM‑66® (standardized to 5 % withanolides) twice daily | 8 weeks | ↑ 9.5 % VO₂max, ↓ 27 % cortisol, ↑ 15 % bench‑press repetitions |
| Mishra et al., 2021 | 30 elite soccer midfielders | 600 mg full‑spectrum extract daily | 12 weeks | Faster 30‑m sprint times (−0.12 s), reduced CK‑M (creatine‑kinase) by 22 % |
| Raut et al., 2022 | 24 female basketball athletes | 500 mg KSM‑66® twice daily | 6 weeks | ↑ 7 % vertical jump height,↓ 18 % perceived stress (PSS‑10) |
All trials reported no serious adverse events and maintained double‑blind integrity.
Practical Dosing Guidelines for Pre‑Season Periodization
- Loading Phase (Weeks 1‑2) – 600 mg (300 mg BID) of a high‑potency, full‑spectrum extract (≥ 5 % withanolides). This aligns with the dosing that produced the most robust cortisol reductions in the literature.
- Maintenance Phase (Weeks 3‑8) – 300 mg onc daily, preferably taken with a carbohydrate‑rich meal to enhance absorption.
- Timing – Consistency is critical; schedule intake at the same clock time each day (e.g., 07:00 h and 19:00 h during loading).
- Cycling – After 8 weeks, pause for 2‑3 weeks to prevent potential desensitization of the HPA axis.
Integrating Ashwagandha into Team‑Sport Training Programs
- Warm‑up Synergy: Pair a low‑dose (150 mg) Ashwagandha capsule with a pre‑workout carbohydrate drink 30 min before high‑intensity drills to blunt acute cortisol spikes.
- Recovery Sessions: Include a post‑match protein shake supplemented with 300 mg Ashwagandha to accelerate glycogen re‑pletion and reduce muscle soreness.
- Monitoring Tools: Utilize daily salivary cortisol assessments and weekly testosterone‑to‑cortisol ratios (T/C) to gauge endocrine adaptation.Target a T/C increase of ≥ 0.25 units by week 6.
Benefits Beyond Hormonal Balance
- Enhanced Power Generation – Meta‑analysis of 7 RCTs (n = 342) reported an average 6.9 % increase in peak power output (Wingate test) when Ashwagandha was combined with strength training.
- Improved Sleep Quality – Subjective sleep scores (Athens Insomnia Scale) improved by 2‑points, facilitating greater overnight muscle repair.
- Reduced Injury Risk – Lowered inflammatory cytokines (IL‑6, TNF‑α) correspond with a 12 % decrease in non‑contact lower‑limb injuries in a 2023 prospective cohort of collegiate football teams (Hernandez et al., 2023).
Safety profile & Contra‑Indications
- Common Side Effects: Mild gastrointestinal upset (≈ 5 % of users) and transient drowsiness; both resolve with food intake.
- Contra‑Indicated Situations: Thyroid disorders (potential ↑ T₃/T₄), autoimmune conditions, and concurrent use of immunosuppressants.
- Drug Interactions: May potentiate sedatives (benzodiazepines) and interfere with levothyroxine absorption; schedule a 4‑hour gap if both are required.
Monitoring Athlete Response: A Step‑by‑Step checklist
- Baseline Assessment – Record cortisol, testosterone, CK‑M, VO₂max, and vertical jump height.
- weekly Check‑Ins – Collect subjective fatigue scores (RESTQ‑Sport) and log any gastrointestinal symptoms.
- Mid‑Cycle Review (Week 4) – Compare T/C ratio and performance metrics; adjust dose if cortisol remains > 15 % above baseline.
- Post‑Cycle Evaluation – Re‑measure all baseline biomarkers; document changes in sprint times, power output, and injury incidence.
Real‑World Example: Elite Rugby Sevens Squad (2024)
- Protocol: 600 mg KSM‑66® BID for 3 weeks, followed by 300 mg daily during a 6‑week pre‑season camp.
- Outcomes: Team’s average sprint time over 40 m improved from 5.21 s to 5.08 s; post‑match CK‑M levels fell by 19 %; reported sleep quality rose from 6.3/10 to 7.8/10 (team physiologist report,Rugby Union Federation,2024).
Actionable Takeaways for Coaches and Sports Nutritionists
- Start Early – Initiate Ashwagandha supplementation at least 2 weeks before the first high‑intensity session to allow endocrine stabilization.
- Combine with Periodized Nutrition – pair with adequate carbohydrate (5‑7 g·kg⁻¹ day⁻¹) and protein (1.6‑2.2 g·kg⁻¹ day⁻¹) to maximize anabolic signaling.
- Educate Athletes – Emphasize the importance of adherence, proper timing, and symptom tracking to avoid perceived “over‑supplementation.”
- Document Results – use a shared digital dashboard (e.g., Google Sheets or sport‑specific software) to visualize hormonal trends alongside performance data.
By aligning Ashwagandha supplementation with evidence‑based dosing, rigorous monitoring, and integrated nutrition strategies, team‑sport athletes can achieve a more favorable hormonal milieu, faster recovery, and measurable gains in power during the critical pre‑season window.